These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. N-cadherin negatively regulates osteoblast proliferation and survival by antagonizing Wnt, ERK and PI3K/Akt signalling. Haÿ E, Nouraud A, Marie PJ. PLoS One; 2009 Dec 14; 4(12):e8284. PubMed ID: 20011526 [Abstract] [Full Text] [Related]
3. Essential role of nuclear factor of activated T cells (NFAT)-mediated Wnt signaling in osteoblast differentiation induced by strontium ranelate. Fromigué O, Haÿ E, Barbara A, Marie PJ. J Biol Chem; 2010 Aug 13; 285(33):25251-8. PubMed ID: 20554534 [Abstract] [Full Text] [Related]
5. BMP9 directly induces rapid GSK3-β phosphorylation in a Wnt-independent manner through class I PI3K-Akt axis in osteoblasts. Eiraku N, Chiba N, Nakamura T, Amir MS, Seong CH, Ohnishi T, Kusuyama J, Noguchi K, Matsuguchi T. FASEB J; 2019 Nov 13; 33(11):12124-12134. PubMed ID: 31365832 [Abstract] [Full Text] [Related]
6. Neural Cell Adhesion Molecule Regulates Osteoblastic Differentiation Through Wnt/β-Catenin and PI3K-Akt Signaling Pathways in MC3T3-E1 Cells. Cheng BF, Feng X, Gao YX, Jian SQ, Liu SR, Wang M, Xie YF, Wang L, Feng ZW, Yang HJ. Front Endocrinol (Lausanne); 2021 Nov 13; 12():657953. PubMed ID: 34054729 [Abstract] [Full Text] [Related]
8. Melatonin promotes osteoblastic differentiation through the BMP/ERK/Wnt signaling pathways. Park KH, Kang JW, Lee EM, Kim JS, Rhee YH, Kim M, Jeong SJ, Park YG, Kim SH. J Pineal Res; 2011 Sep 13; 51(2):187-94. PubMed ID: 21470302 [Abstract] [Full Text] [Related]
12. Wnt5a and Wnt11 inhibit the canonical Wnt pathway and promote cardiac progenitor development via the Caspase-dependent degradation of AKT. Bisson JA, Mills B, Paul Helt JC, Zwaka TP, Cohen ED. Dev Biol; 2015 Feb 01; 398(1):80-96. PubMed ID: 25482987 [Abstract] [Full Text] [Related]
16. N-cadherin interacts with axin and LRP5 to negatively regulate Wnt/beta-catenin signaling, osteoblast function, and bone formation. Haÿ E, Laplantine E, Geoffroy V, Frain M, Kohler T, Müller R, Marie PJ. Mol Cell Biol; 2009 Feb 01; 29(4):953-64. PubMed ID: 19075000 [Abstract] [Full Text] [Related]
17. Cross-talk between Wnt and bone morphogenetic protein 2 (BMP-2) signaling in differentiation pathway of C2C12 myoblasts. Nakashima A, Katagiri T, Tamura M. J Biol Chem; 2005 Nov 11; 280(45):37660-8. PubMed ID: 16150699 [Abstract] [Full Text] [Related]
18. Prostate cancer induces bone metastasis through Wnt-induced bone morphogenetic protein-dependent and independent mechanisms. Dai J, Hall CL, Escara-Wilke J, Mizokami A, Keller JM, Keller ET. Cancer Res; 2008 Jul 15; 68(14):5785-94. PubMed ID: 18632632 [Abstract] [Full Text] [Related]
19. Downregulation of ErbB3 by Wnt3a contributes to wnt-induced osteoblast differentiation in mesenchymal cells. Jullien N, Maudinet A, Leloutre B, Ringe J, Häupl T, Marie PJ. J Cell Biochem; 2012 Jun 15; 113(6):2047-56. PubMed ID: 22274864 [Abstract] [Full Text] [Related]
20. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma. Qiang YW, Barlogie B, Rudikoff S, Shaughnessy JD. Bone; 2008 Apr 15; 42(4):669-80. PubMed ID: 18294945 [Abstract] [Full Text] [Related] Page: [Next] [New Search]